An increase in the renal resistive index (RRI) in patients with essential hypertension (EH) predicts deterioration in renal function. In patients with EH, changes in hemodynamic parameters significantly affect the RRI. This study aimed to define changes in Ambulatory Blood Pressure Monitoring (ABPM) parameters that are significantly associated with a change in RRI in patients with EH. We evaluated ABPM and the RRI in 96 patients with EH without organ extrarenal changes at baseline and after two years of follow-up. The relationships between changes in ABPM parameters and the RRI over the period were evaluated. After two years of follow-up, the increase in RRI was consequential. Simultaneously, 24-h systolic blood pressure increased significantly and 24-h diastolic blood pressure decreased. In the whole group and in the group with calculated cystatin C clearance (eGFRcyst) >/=90 ml/min/1.73 m2, the change in RRI significantly negatively correlated with the change in the ratio of 24-h diastolic to systolic blood pressure (D/S ratio), but also with the change in 24-h pulse blood pressure. However, in patients with eGFRcyst>90 ml/min/1.73 m2, only the change in the 24-h D/S ratio significantly correlated with the change in RRI. Based on the backward stepwise regression analysis, the change in RRI was significantly dependent only on the change in 24-h D/S ratio and not on the change in 24-h pulse pressure. A change in the ratio of diastolic to systolic pressure better reflects a change in RRI than a change in pulse pressure.

Department of Internal Medicine Masaryk Hospital Usti nad Labem Czech Republic; Department of Internal Medicine 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol Prague Czech Republic

See more in PubMed

Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens. 2014;32:149–153. doi: 10.1097/HJH.0b013e328365b29c. PubMed DOI PMC

Boddi M. Renal ultrasound (and Doppler sonography) in hypertension: An update. Adv Exp Med Biol. 2017;956:191–208. doi: 10.1007/5584_2016_170. PubMed DOI

Andrikou I, Tsioufis C, Konstantinidis D, Kasiakogias A, Dimitriadis K, Leontsinis I, Andrikou E, Sanidas E, Kallikazaros I, Tousoulis D. Renal resistive index in hypertensive patients. J Clin Hypertens (Greenwich) 2018;20:1739–1744. doi: 10.1111/jch.13410. PubMed DOI PMC

Rosolova H, Nussbaumerova B, Mayer O, Cifkova R, Bruthans J. Success and Failure of Cardiovascular Disease Prevention in Czech Republic Over the Past 30 Years. Czech Part of the EUROASPIRE I–IV Surveys. Physiol Res. 2017;66(Suppl 1):S77–S84. doi: 10.33549/physiolres.933598. PubMed DOI

Pařenica J, Kala P, Jarkovský J, Poloczek M, Boček O, Jeřábek P, Neugebauer P, et al. Relationship between high aortic pulse pressure and extension of coronary atherosclerosis in males. Physiol Res. 2011;60:47–53. doi: 10.33549/physiolres.931957. PubMed DOI

Judd E, Calhoun DA. Management of hypertension in CKD: Beyond the guidelines. Adv Chronic Kidney Dis. 2015;22:116–122. doi: 10.1053/j.ackd.2014.12.001. PubMed DOI PMC

Barri YM. Hypertension and kidney disease: A deadly connection. Curr Hypertens Rep. 2008;10:39–45. doi: 10.1007/s11906-008-0009-y. PubMed DOI

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646–661. doi: 10.1053/ajkd.2000.16225. PubMed DOI

Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K, Shimaoka I, et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrol Dial Transplant. 2011;26:3256–3262. doi: 10.1093/ndt/gfr054. PubMed DOI

Kim ES, Kim HJ, Kim YJ, Lee SM, Lee HJ, Cho DS, Son YK, et al. Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients. Kidney Res Clin Pract. 2013;32:158–163. doi: 10.1016/j.krcp.2013.09.002. PubMed DOI PMC

Kotruchin P, Hoshide S, Ueno H, Komori T, Kario K. Lower systolic blood pressure and cardiovascular event risk stratified by renal resistive index in hospitalized cardiovascular patients: J-VAS study. Am J Hypertens. 2019;32:365–374. doi: 10.1093/ajh/hpy189. PubMed DOI

Brardi S, Cevenini G. Low systolic blood pressure values, renal resistive index measurement and glomerular filtration rate in a non-dialysis dependent chronic kidney disease population. Arch Ital Urol Androl. 2019;90:288–292. doi: 10.4081/aiua.2018.4.288. PubMed DOI

Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967. doi: 10.1016/S0140-6736(15)01225-8. PubMed DOI

Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435–443. doi: 10.1016/S0140-6736(15)00805-3. PubMed DOI

Judson GL, Rubinsky AD, Shlipak MG, Katz R, Kramer H, Jacobs DR, Jr, Odden MC, Peralta CA, et al. Longitudinal blood pressure changes and kidney function decline in persons without chronic kidney disease: Findings from the MESA study. Am J Hypertens. 2018;31:600–608. doi: 10.1093/ajh/hpx177. PubMed DOI PMC

Oliveira RAG, Mendes PV, Park M, Taniguchi LU. Factors associated with renal Doppler resistive index in critically ill patients: a prospective cohort study. Ann Intensive Care. 2019;9:23. doi: 10.1186/s13613-019-0500-4. PubMed DOI PMC

Cilsal E, Koc AS. Renal resistive index significantly increased in hypertensive children and it is independently related to the pulse pressure and left ventricular mass index. Clin Exp Hypertens. 2019;41:607–614. doi: 10.1080/10641963.2018.1523920. PubMed DOI

Akaishi T, Abe M, Miki T, Miki M, Funamizu Y, Ito S, Abe T, Ishii T, et al. Ratio of diastolic to systolic blood pressure represents renal resistive index. J Hum Hypertens. 2020;34:512–519. doi: 10.1038/s41371-019-0264-1. PubMed DOI PMC

Sveceny J, Charvat J, Hrach K, Horackova M, Schück O. Association between 24-hour diastolic blood pressure and renal function in patients receiving treatment for essential hypertension. J Int Med Res. 2019;47:4958–4967. doi: 10.1177/0300060519867805. PubMed DOI PMC

Devereux RB, Koren MJ, de Simone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J. 1993;14(Suppl D):8–15. doi: 10.1093/eurheartj/14.suppl_d.8. PubMed DOI

Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37:7–11. doi: 10.1016/0002-9149(76)90491-4. PubMed DOI

Chaumont M, Pourcelet A, van Nuffelen M, Racapé J, Leeman M, Hougardy JM. Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk? J Clin Hypertens (Greenwich) 2016;18:514–521. doi: 10.1111/jch.12795. PubMed DOI PMC

Balietti P, Spannella F, Giulietti F, Rosettani G, Bernardi B, Cocci G, Bonfigli AR, Sarzani R, et al. Ten-year changes in ambulatory blood pressure: the prognostic value of ambulatory pulse pressure. J Clin Hypertens (Greenwich) 2018;20:1230–1237. doi: 10.1111/jch.13344. PubMed DOI PMC

Velasquez MT, Beddhu S, Nobakht E, Rahman M, Raj DS. Ambulatory blood pressure in chronic kidney disease: ready for prime time? Kidney Int Rep. 2016;1:94–104. doi: 10.1016/j.ekir.2016.05.001. PubMed DOI PMC

Ogawa-Akiyama A, Sugiyama H, Kitagawa M, Tanaka K, Onishi A, Yamanari T, Morinaga H, et al. Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease. PLoS One. 2018;13:e0193695. doi: 10.1371/journal.pone.0193695. PubMed DOI PMC

Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini R, Miccoli R, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53:480–488. doi: 10.1373/clinchem.2006.076042. PubMed DOI